Cargando…

SPOP targets the immune transcription factor IRF1 for proteasomal degradation

Adaptation of the functional proteome is essential to counter pathogens during infection, yet precisely timed degradation of these response proteins after pathogen clearance is likewise key to preventing autoimmunity. Interferon regulatory factor 1 (IRF1) plays an essential role as a transcription f...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Irene, Vunjak, Milica, Budroni, Valentina, Cantoran García, Adriana, Mastrovito, Marialaura, Soderholm, Adrian, Hinterndorfer, Matthias, de Almeida, Melanie, Hacker, Kathrin, Wang, Jingkui, Froussios, Kimon, Jude, Julian, Decker, Thomas, Zuber, Johannes, Versteeg, Gijs A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491434/
https://www.ncbi.nlm.nih.gov/pubmed/37622993
http://dx.doi.org/10.7554/eLife.89951
_version_ 1785104057252184064
author Schwartz, Irene
Vunjak, Milica
Budroni, Valentina
Cantoran García, Adriana
Mastrovito, Marialaura
Soderholm, Adrian
Hinterndorfer, Matthias
de Almeida, Melanie
Hacker, Kathrin
Wang, Jingkui
Froussios, Kimon
Jude, Julian
Decker, Thomas
Zuber, Johannes
Versteeg, Gijs A
author_facet Schwartz, Irene
Vunjak, Milica
Budroni, Valentina
Cantoran García, Adriana
Mastrovito, Marialaura
Soderholm, Adrian
Hinterndorfer, Matthias
de Almeida, Melanie
Hacker, Kathrin
Wang, Jingkui
Froussios, Kimon
Jude, Julian
Decker, Thomas
Zuber, Johannes
Versteeg, Gijs A
author_sort Schwartz, Irene
collection PubMed
description Adaptation of the functional proteome is essential to counter pathogens during infection, yet precisely timed degradation of these response proteins after pathogen clearance is likewise key to preventing autoimmunity. Interferon regulatory factor 1 (IRF1) plays an essential role as a transcription factor in driving the expression of immune response genes during infection. The striking difference in functional output with other IRFs is that IRF1 also drives the expression of various cell cycle inhibiting factors, making it an important tumor suppressor. Thus, it is critical to regulate the abundance of IRF1 to achieve a ‘Goldilocks’ zone in which there is sufficient IRF1 to prevent tumorigenesis, yet not too much which could drive excessive immune activation. Using genetic screening, we identified the E3 ligase receptor speckle type BTB/POZ protein (SPOP) to mediate IRF1 proteasomal turnover in human and mouse cells. We identified S/T-rich degrons in IRF1 required for its SPOP MATH domain-dependent turnover. In the absence of SPOP, elevated IRF1 protein levels functionally increased IRF1-dependent cellular responses, underpinning the biological significance of SPOP in curtailing IRF1 protein abundance.
format Online
Article
Text
id pubmed-10491434
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-104914342023-09-09 SPOP targets the immune transcription factor IRF1 for proteasomal degradation Schwartz, Irene Vunjak, Milica Budroni, Valentina Cantoran García, Adriana Mastrovito, Marialaura Soderholm, Adrian Hinterndorfer, Matthias de Almeida, Melanie Hacker, Kathrin Wang, Jingkui Froussios, Kimon Jude, Julian Decker, Thomas Zuber, Johannes Versteeg, Gijs A eLife Immunology and Inflammation Adaptation of the functional proteome is essential to counter pathogens during infection, yet precisely timed degradation of these response proteins after pathogen clearance is likewise key to preventing autoimmunity. Interferon regulatory factor 1 (IRF1) plays an essential role as a transcription factor in driving the expression of immune response genes during infection. The striking difference in functional output with other IRFs is that IRF1 also drives the expression of various cell cycle inhibiting factors, making it an important tumor suppressor. Thus, it is critical to regulate the abundance of IRF1 to achieve a ‘Goldilocks’ zone in which there is sufficient IRF1 to prevent tumorigenesis, yet not too much which could drive excessive immune activation. Using genetic screening, we identified the E3 ligase receptor speckle type BTB/POZ protein (SPOP) to mediate IRF1 proteasomal turnover in human and mouse cells. We identified S/T-rich degrons in IRF1 required for its SPOP MATH domain-dependent turnover. In the absence of SPOP, elevated IRF1 protein levels functionally increased IRF1-dependent cellular responses, underpinning the biological significance of SPOP in curtailing IRF1 protein abundance. eLife Sciences Publications, Ltd 2023-08-25 /pmc/articles/PMC10491434/ /pubmed/37622993 http://dx.doi.org/10.7554/eLife.89951 Text en © 2023, Schwartz, Vunjak, Budroni et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Immunology and Inflammation
Schwartz, Irene
Vunjak, Milica
Budroni, Valentina
Cantoran García, Adriana
Mastrovito, Marialaura
Soderholm, Adrian
Hinterndorfer, Matthias
de Almeida, Melanie
Hacker, Kathrin
Wang, Jingkui
Froussios, Kimon
Jude, Julian
Decker, Thomas
Zuber, Johannes
Versteeg, Gijs A
SPOP targets the immune transcription factor IRF1 for proteasomal degradation
title SPOP targets the immune transcription factor IRF1 for proteasomal degradation
title_full SPOP targets the immune transcription factor IRF1 for proteasomal degradation
title_fullStr SPOP targets the immune transcription factor IRF1 for proteasomal degradation
title_full_unstemmed SPOP targets the immune transcription factor IRF1 for proteasomal degradation
title_short SPOP targets the immune transcription factor IRF1 for proteasomal degradation
title_sort spop targets the immune transcription factor irf1 for proteasomal degradation
topic Immunology and Inflammation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491434/
https://www.ncbi.nlm.nih.gov/pubmed/37622993
http://dx.doi.org/10.7554/eLife.89951
work_keys_str_mv AT schwartzirene spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT vunjakmilica spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT budronivalentina spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT cantorangarciaadriana spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT mastrovitomarialaura spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT soderholmadrian spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT hinterndorfermatthias spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT dealmeidamelanie spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT hackerkathrin spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT wangjingkui spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT froussioskimon spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT judejulian spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT deckerthomas spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT zuberjohannes spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation
AT versteeggijsa spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation